Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 2,001–2,099 of 2,099
Xu, M., Liu, Z., Zhou, J., Lv, J., An, Q., Zhang, Y., & LIU, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02250-w · Cited by 1
“Skeletal muscle is a primary site of insulin-stimulated glucose disposal, accounting for a significant portion of whole-body glucose uptake [10, 11].”
Amine, H. (2016) · theses.fr (ABES) · doi:10.70675/8fc153dfzc95cz4209zabf7z1567442c940d
“La résistance à l’insuline : La résistance à l’insuline est définie comme étant une incapacité de l’insuline à favoriser le transport du glucose de la circulation sanguine vers les tissus cibles (DeFronzo and Tripathy, 2009).”
Li, Z., Qiu, X., Wu, W., & Hyunsik, K. A. N. G. (2026) · Science Progress · doi:10.1177/00368504261440964
Laget, J. (2019) · theses.fr (ABES) · doi:10.70675/ed653ea5z6ff4z4915za368z0d23f0cd9829 · Cited by 1
Akar, E. A. (2022) · theses.fr (ABES) · doi:10.70675/a7b15e3fz84e7z4915z9447zc112181e06e4
Ümit, F., Çiftçi, G., Onuk, B., Acı, R., Çaka, Ö., & ÇİFTCİ, A. (2026) · Veterinary Medicine and Science · doi:10.1002/vms3.70942
Identification of new levers to fight muscle atrophy : benefit of the hibernating brown bear model
Cussonneau, L. (2022) · theses.fr (ABES) · doi:10.70675/1a11a81bzf829z4ba2zba9az6f3f4841c773
Wu, D., Chen, X., HUANG, D., Huang, Z., Zheng, N., Chen, J., Xue, X., & Cai, Z. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113126
Predicting stress-induced vulnerability to depression in diabetes
Alaeddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/41d9cd78zd5dez4ccfzae36zbb176db78e3f
Ganisetti, D., & Chaudhry, K. (2026) · Cureus · doi:10.7759/cureus.106642
“Prediabetes represents an early abnormal glucose regulation marked by insulin resistance, chronic low-grade inflammation, oxidative stress, and impaired neuromuscular function [5,6].”
Lysosomal defects in Duchenne muscular dystrophy : advancing combined therapeutic approaches
Jaber, A. (2024) · theses.fr (ABES) · doi:10.70675/d5d1c272z2c2cz4571zb9ccz8134fc1276c2
Burn-associated metabolic dysfunction: could extracellular vesicles play a role?
Farahat, M., Dadashizadeh, G., Ricciuti, Z., Pappas, A., & Jeschke, M. G. (2026) · Clinical Science · doi:10.1042/cs20260147 · Cited by 1
“Moreover, the insulin-resistant state of skeletal muscles is considered a leading cause of type 2 diabetes development [59].”
Yin, X., Peng, H., Song, Y., Yao, N., Shen, Z., Jiang, Y., Chen, H., Huang, L., He, Z., Li, P., et al. (2026) · Medicine · doi:10.1097/md.0000000000048182 · Cited by 1
“[57] On the metabolic front, it induces insulin resistance and disrupts the regulation of adipokines such as leptin [58] and adiponectin, [59] thereby forming a biological bridge linking sarcopenia to cognitive decline.”
Cheng, Z., Fu, F., Lin, H., Han, Z., & Xu, T. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108953
Su, X., Du, Y., Yang, Y., Zhao, Y., Zhao, H., Xie, J., Shan, Z., Wang, M., Huang, Z., Fu, W., et al. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/8023146
Sharath, S., Maiya, G. A., Kadavigere, R., Prakashini, K., & Nagri, S. K. (2026) · F1000Research · doi:10.12688/f1000research.178108.1
Lier, P. M. G. V., van de Weijer, T., Vanweert, F., Brouwers, K., Nijssen, K. M. R., Schaart, G., Moonen‐Kornips, E., van Beek, S. M. M., Springer, S., Wierts, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71897-9
“In healthy individuals, skeletal muscle plays a crucial role in maintaining glucose homeostasis, as postprandial, insulin-stimulated glucose uptake by skeletal muscle accounts for approximately 80% of total glucose disposal 2 – 5 .”
Metabolic Crosstalk Between Skeletal Muscle and Visceral Organs in Disease States
Alani, Z. (2026) · Physiology · doi:10.5772/intechopen.1014646
Age-Related Changes of the Adipose Tissue in Different Body Areas
Alfertshofer, M. G., Hartmann, R., & Brébant, V. (2026) · Springer eBooks · doi:10.1007/978-3-032-01711-6_18
Stanley, T. L. (2026) · Contemporary Endocrinology · doi:10.1007/978-3-032-17036-1_6
Seo, D.-J., Kim, H. J., Kim, Y. S., Mun, J., Leem, J., Park, S., Lee, D., & Kim, H. (2026) · Annals of Occupational and Environmental Medicine · doi:10.35371/aoem.2026.38.e14
“14 An increase in skeletal muscle mass enhances muscle strength; when insulin secretion effectively promotes glucose transport into muscles, glycemic control can be considered favorable.”
Unearthing the bioactive properties of potato ( Solanum tuberosum ) for improving metabolic health
Iniguez, A. B., Sun, Q., Du, ., & Zhu, M. J. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2662981 · Cited by 1
“It is associated with an increased risk of cardiovascular disease (CVD), T2D, and premature mortality (Moreira et al. 2014; Noubiap et al. 2022; Mohamed et al. 2023).”
InfluentialRyu, S., Choi, J. S., & Yang, Y.-M. (2026) · Medicine · doi:10.1097/md.0000000000048785
“[36] The combination of visceral fat accumulation and sarcopenia—a phenotype termed “sarcopenic obesity”-has been shown to markedly increase diabetes risk through synergistic effects on insulin resistance and mitochondrial dysfunction.”
The Pathophysiology of Cardio-Renal Interactions
Çöpür, S., & Kanbay, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-25434-4_3
Kumar, P., Babalola, B. A., Qu, Z., Waiker, D. K., Moorthy, N. H. N., Tiwari, A., Chourasiya, A., Kiriwan, D., Martins, F. G., Sousa, S. F., et al. (2026) · 3 Biotech · doi:10.1007/s13205-026-04824-w
Ali, A., Hakam, H.-K., Eter, A., Bazzi, S., Chahine, A., Akle, C. A., Bahr, G. M., & Echtay, K. S. (2026) · Nutrients · doi:10.3390/nu18111652
“…weight, blood and urine glucose levels, serum insulin and C -peptide levels, and protein expression levels of glucose transporters and oxidative stress-related enzymes, mainly in the liver and SM tissues that are particularly vulnerable to hyperglycemia-driven mitochondrial dysfunction [19–21].”
Zhang, X., Jiang, C., Li, J., Jing, Z., Song, Y., Peng, L., Liu, B., & Meng, H. (2026) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.26-00041
“The co-occurrence of these two abnormalities may be associated with a heightened metabolic vulnerability, potentially predisposing individuals to a faster accumulation of chronic physical conditions such as hyperglycemia, hyperlipidemia, and cardiovascular disease [28, 29].”
Li, P., Chang, J., Zhang, X., & Han, D. (2026) · Brain Circulation · doi:10.4103/bc.bc_200_25 · Cited by 1
McGilvrey, M. I., Chew, S., Siddiqui, M. F., Bronson, R., Uslu, M., Ye, S., Ospina, O., Mcpherson, A., Diel, K., Dogsa, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726943
Ani, O. G., Rabbani, E., & Dhillon, J. (2026) · medRxiv · doi:10.64898/2026.05.27.26354244
Trybulski, R., Żebrowska, A., Fostiak, K., Olaniszyn, G., & Wilk, M. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156671 · Cited by 1
Lim, Y., Ma, M.-J., Son, W., Kang, S., Choi, J.-H., Shim, B.-J., Seo, M., & Park, W.-T. (2026) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2026.43.39
“It constitutes approximately 40% of the total body mass and plays vital roles in locomotion, glucose metabolism, energy balance, and systemic physiological regulation [4,5].”
Kpablitey, I. L., Ofori, E. K., Nyarko, E. N. Y., Ateko, R. O., Amponsah, S. K., Issahaku, A., Assan, N. A., Amugi, C. N., Asare‐Anane, H., & Yawson, A. E. (2026) · Sage Open Aging · doi:10.1177/30495334261456207
“Furthermore, sMM was inversely associated with sarcopenia risk and IR, suggesting a potential relationship, and underscoring the detrimental effects of reduced muscle mass on metabolic health and insulin sensitivity (DeFronzo & Tripathy, 2009).”
Abdu, F. A., Mohammed, A., Zhang, W., Alifu, J., Liu, L., Yin, G., Liao, Y., Zhu, G., & Che, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03244-7
“Skeletal muscle accounts for approximately 80% of insulin-stimulated glucose disposal, and insulin resistance in this tissue is established as the primary defect driving progression of prediabetes and associated cardio-vascular risk [55, 56].”
Kravets, K. K., & Drozdovska, S. (2026) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.26.2.144
People who lift weights live longer – new study
McNamara, J. (2026) · The Conversation · doi:10.64628/ab.kydvaapc3
Huang, Y. Q. (2026) · Medicine · doi:10.1097/md.0000000000049366
“[37,38] At lower MQI levels, reduced muscle quality may lead to metabolic dysfunction via decreased myokine secretion [39] and the presence of sarcopenic obesity, which promotes chronic systemic inflammation.”
Quem pratica musculação vive mais, aponta novo estudo
McNamara, J. (2026) · The Conversation · doi:10.64628/ade.wp3hq3tmd
San-Millán, I., Martinez, J. L., Sparagna, G. C., D’Alessandro, A., Stefanoni, D., Nemkov, T. G., & Hill, J. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2030010 · Cited by 7
“Skeletal muscle is responsible for ~80–85% of glucose disposal under resting and hyperinsulinemic–euglycemic postprandial conditions [18], and therefore it is a critical site for studying cellular metabolism, mitochondrial function, and bioenergetics.”
Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology
Eldib, M., Fierro, F. E., Abad, M. O., & Correa, R. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71022 · Cited by 1
“In skeletal muscle and adipocytes, they reduce glucose uptake by inhibiting insulin receptor protein kinases and GLUT4 translocation [68–70 , 73].”
Hazaveh, M. M., Shojaei, S., Mousavi, A., Zooravar, D., Aghamohamadpour, S., Yousefifar, S., Talebpour, M., & Radkhah, H. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02001-7
“This is based on the mechanism whereby IR elevates plasma glucose and promotes hepatic [43–49] 43 [40-49.7] 45 [42-47.7] 35 [33–37] 37 [34–37] 35 [31-36.7] 35 [33–40] 32 [29–34] 33 [33–34] 30 [27.5–33] 31.5 [28.25–35.”
InfluentialPlant-based Diets and Diabetes
Slywitch, E. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837678907-00310 · Cited by 1
GULP1 enhances GLUT4 translocation by counteracting ACAP1–ARF6 inhibition
Wen, X., Mei, J., Jiang, Y., Qian, M., Wang, J., Xu, S., Xu, L., Xu, L., Liu, Q., Zhao, M., et al. (2026) · Nutrition and Diabetes · doi:10.1038/s41387-026-00452-8
“Adipose dysfunction can lead to abnormal secretion of adipokines, including exosomal miRNAs, inducing insulin resistance in adipose tissue, muscle, and liver, thereby driving obesity-related T2DM [8 – 15].”
Huo, J., Li, F., Wang, T., Tang, S., Xi, Y., & Xie, G. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/1195681
“…who demonstrated in a Chinese adult population ( ≥ 45 years) that IR mediates approximately 11.78% of the total efect on low muscle mass. Accounting for 40%–50% of adult lean mass, skeletal muscle is a tissue sensitive to insulin [31–33] and the main location for glucose uptake mediated by insulin.”
InfluentialGuan, Z., Stephan, B. C. M., & Siervo, M. (2026) · Diabetes Care · doi:10.2337/dc26-0797 · Cited by 1
Periodontitis and physical activity: a scoping review
Contreras-León, J., Herrera-Atoche, J. R., Carrillo-Ávila, B. A., Martínez-Aguilar, V. M., Díaz‐Zúñiga, J., & Melgar‐Rodríguez, S. (2026) · Frontiers in Oral Health · doi:10.3389/froh.2026.1786143
“In humans, skeletal muscle is the primary tissue responsible for glucose uptake in both the postprandial state and under conditions of euglycemic hyperinsulinemia (7).”
Marchant, E. D., Kalenta, H., Kilroe, S. P., May, J. T., Martini, W. Z., Weldon, K. S., Lai, Z., & Rasmussen, B. B. (2026) · Function · doi:10.1152/function.039.2026 · Cited by 1
“Insulin resistance in skeletal muscle is considered a primary driver in the development of type II diabetes (1).”
LORENZO, R. D., & Rovere, P. Q. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108345
Underlying mechanisms of exercise protection against diabetes mellitus: a narrative review
Wang, S., Lü, F., Liu, Y., Xu, R., Zhang, G., Miao, Y., Lu, S., Liu, Z., Huang, W. Q., Meng, J., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1854074
“Skeletal muscle, being the major tissue for glucose disposal stimulated by insulin, develops IR that constitutes a core mechanism underlying the pathogenesis of T2DM (100).”
Insulin Action in Liver, Skeletal, Muscle, and Adipose Tissue: A Focus on Humans
Trinks, N., Schön, M., Gancheva, S., & Roden, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00009-3
Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy
Belančić, A., Skroče, K., Gkrinia, E. M. M., Glavić, M. M., & Kwok, M. K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15155870 · Cited by 3
Farhan, Z., Saeed, R., Mahgoub, E., Khalique, A., & Taneera, J. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168385
Fu, Y., Zeng, X., Zhou, B., Wang, J.-Y., & Qin, H. (2026) · Nutrients · doi:10.3390/nu18152431
“Under euglycaemic-hyperinsulinaemic clamp conditions, skeletal muscle accounts for roughly 80% of whole-body insulin-stimulated glucose disposal, making it the primary insulin-responsive tissue and chief determinant of systemic glycaemic control [4,5].”
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_13
Timing the strain: skeletal muscle clock as regulator of physical activity
Kawano, I., & Asher, G. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00121-5
“Skeletal muscle is the primary site of postprandial glucose disposal and a major target of insulin action 38 .”
THE ROLE OF RESISTANCE TRAINING IN MODULATING INSULIN RESISTANCE: A NARRATIVE REVIEW
Deska, G., Wójtowicz, K., Wawrzeczko, A., Jakubiec, M. K., Jankowska, A., Gostół, M., Górska, N., Gąsiorowska, E., & Lewczuk, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5411
Zhang, R., Yu, D., Liu, X., Xue, H., Xie, J., & Wang, L. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02247-4
“Accordingly, impaired skeletal muscle glucose uptake is closely linked to insulin resistance and may represent an early metabolic abnormality before overt hyperglycemia develops [55].”
Ghazi, H. A., Ghaly, C. M., & Ibrahim, H. N. (2026) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_11_26
Soft Tissue Radiodensity Asymmetry as Clinical Indicator for Diabetes and Hypertension in Aging
Recenti, M., Ponsiglione, A. M., Ricciardi, C., Russo, M., Edmunds, K. J., Amato, F., Gíslason, M. K., Carraro, U., Chang, M., & Gargiulo, P. (2026) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2026.3718689
“Given that skeletal muscle is the primary site for glucose disposal, a decline in muscle mass can lead to impaired glucose metabolism, raising the risk of DM in older adults [46].”
Ruan, G., Guo, X., Zhang, W., & Cai, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1895584
“Skeletal muscle is the primary tissue responsible for insulin-stimulated glucose disposal, accounting for up to 80% of glucose clearance during an insulin infusion (29).”
Todorova, G., Gesheva, T., & Mihaylova, A. (2026) · European Journal of Translational Myology · doi:10.4081/ejtm.2026.15541
Xiao, P., Cheng, H., Xiong, J., Yan, Y., Liu, J., Liu, L., Dong, H., Li, Y., Ye, P., Fu, L., et al. (2026) · Diabetes · doi:10.2337/db26-0136
From NAD+ metabolism to skeletal muscle function: The emerging role of ADP-ribosylation
Yonamine, C. Y., Espino-González, E., Lozano, S. P. A., & Treebak, J. T. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117866
Maddox, A., Manickam, N., Orchard, P., Erdos, M. R., Narisu, N., Stringham, H. M., Lakka, T. A., Saramies, J., Laakso, M., Tuomilehto, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.17.745340
PARK, Y., SHIN, Y.-H., Yuan, Y., Jeon, J. Y., Zhang, Y., Ferrari, G., Rezende, L. F. M., Giovannucci, E. L., & Lee, D. H. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113509
Bates, G. T., Bultitude, W. P., Greig, J., McClellan, A., Pinotsis, N., Ramsahye, P., Siu, W. S., Kamuda, K., Chiozzi, R. Z., Thalassinos, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.20.745084
Franków, M., Kudłacik, A., Jarosz, K. A., Schmidt, A. K., Żmuda, A. R., Całusińska-Skowron, M., Łukasik, J., Jeziorowska, K., Bałdys, K., & Kaczmarek, O. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6431
Wang, C., Kanaley, J. A., Chen, J., & Tan, J. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1907805
Carvacrol Mitigates TNF‐α‐Driven Oxidative and Bioenergetic Impairment in L6 Rat Myoblasts
Albarrati, A., & Nazer, R. I. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.71087
Fu, S., Meng, Y., Liang, K., & Feng, M. (2026) · Biomolecules · doi:10.3390/biom16091238
“Skeletal muscle is a major site of insulin-stimulated glucose disposal and a key metabolic tissue affected by diabetes [202].”
Wang, W., Czakyrowa, A. J., Rohmann, N., Hartmann, K., Kruse, L., Türk, K., Bang, C., Franke, A., Laudes, M., & Geisler, C. (2026) · Research Square · doi:10.21203/rs.3.rs-10654191/v1
Al-Qurain, A. A., Alsultan, A. K., Alamoudi, M. K., Almohaywi, M., Shakoori, A., Gharash, H. A., Alsaffar, N., & Alrossies, A. S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1903467
“Prior research has demonstrated that diabetes induces changes in skeletal muscle structure and function, thereby potentially altering muscle biomarker profiles without necessarily signifying clinically relevant muscle damage (34, 35).”
miRNAs as cell-intrinsic epigenetic regulators in muscle in type 2 diabetes
Nawaz, A., Lino, M., Haider, N., Gomes, A. S., Ghosh, A., Satake, E., Gattu, A. K., & Kahn, C. R. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02846-7
“1,2 We have previously shown that myoblasts derived from iPS cells (iMyos) from people with T2D, as well as from people with insulin resistance but without diabetes, exhibit defects in insulin signaling, insulin-stimulated glucose uptake, mitochondrial function, and protein expression in vitro.”
Lazar, M. V., Mathew, P. J., & Thomas, J. P. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02065-5
Teofilović, B. D., Trkulja, J., Grujić-Letić, N. N., Gligorić, E. I., Baletic, D., Tomić, L., Mesarović, A., & Rašković, A. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2727202
van der Meer, R., Monpellier, V. M., Liem, R. S. L., Janssen, I. M. C., Hazebroek, E. J., & Serlie, M. J. M. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101441
Liu, Y., Xu, M., Ke, C., Xiao, Y., Sun, M., Tang, B., & Zhang, W. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113557
Cui, H., Nisar, A., Duan, Z., Mao, J., Zhu, H., Li, L., Cao, X., He, Y., & Li, W. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108443
Avdeeva, K. S., Gorbachevskii, A. V., Petelina, T. I., Enina, T. N., Невмержицкий, В. С., Antyukh, K. Y., Григоренко, Е. А., & Митьковская, Н. П. (2026) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.3.008
Ma, M., Ma, X., Pan, H., Lyu, W., Zhang, F., & Zhang, J. (2026) · Healthcare · doi:10.3390/healthcare14182966
“Mechanistically, skeletal muscle is the major site of insulin-stimulated glucose disposal, accounting for approximately 80–90% of glucose uptake under normal physiological conditions [35].”
Wang, H., Ji, S., Gan, Y., Luo, R., & Dai, K. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1892429
“This distribution is similar to the epidemiological features of frailty in middle-aged and older adults reported by the China Health and Retirement Longitudinal Study (CHARLS) (35), but lower than the prevalence of frailty in European and American populations (approximately 24”
Wang, X., Yang, W., Song, S., Su, H., & Zhang, Y. (2026) · Genes · doi:10.3390/genes17091154
“Reduced muscle mass may be associated with impaired glucose disposal, insulin resistance, and ectopic lipid deposition [5,6,65].”
Huang, X., Duan, J., Liang, X., Li, Y., & Zhao, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1923121
“Patients with T2DM are at substantially higher risk of sarcopenia, which is associated with functional decline, falls, hospitalization, reduced quality of life, and increased mortality (4).”
InfluentialCiotlos, D. L., Hanks, S. C., Varshney, A., Erdos, M. R., Manickam, N., Stringham, H. M., ORCHARD, P., Hill‐Burns, E. M., Narisu, N., Bonnycastle, L. L., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117293
Dağ, N., Dündar, İ., Güngör, Ş., Taşolar, S., Ulubaba, H. E., akyol, R., & Güngör, E. D. (2026) · Children · doi:10.3390/children13101320
Raj, S., Suvarna, R., Thunga, G., S, V. B., & Shetty, S. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121103
Cui, J., 李红光, Liu, J., Liu, M., & Zhao, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1952532
GLP-1 as a Regulator of Oxidative Signalling in Metabolic Health and Disease
Kurhaluk, N., Kołodziejska, R., & Ткаченко, Г. М. (2026) · Antioxidants · doi:10.3390/antiox15101283 · Cited by 1
Role for the endothelial glycocalyx in regulation of insulin sensitivity in muscle
Eskens, B. J. M. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140523be
Casale, C. (2015) · UCL Discovery (University College London)
Andrews, J. R. (2012) · The Knowledge Bank (The Ohio State University)
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.